Search results (115)
« Back to NewsGlobal inequities in maternal health risks across a woman’s life
25 October 2024
New findings published in The Lancet Global Health expose substantial global and regional disparities in the cumulative burden of life-threatening maternal morbidity across the female reproductive life span.
Long COVID study highlights need for diagnosis and management investment
23 October 2024
A new study from researchers in the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), hosted at NDM’s Pandemic Sciences Institute, reveals the key Long COVID characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly.
The Global Health Network MENA Regional Hub officially launched
22 October 2024
The Global Health Network, hosted by NDM, proudly announced the official launch of its Middle East North Africa (MENA) Regional Hub, an initiative set to revolutionise health research, education, and practice across the region. The launch event was held at the Canadian University Dubai on the 21st October 2024, and brought together leading experts, policymakers, and academic institutions to chart a path toward a healthier and more resilient future for the MENA region.
Nigeria rolls out new Oxford R21 malaria vaccine
18 October 2024
On Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M™ malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country’s fight against the deadly disease.
Possible new transmission route for highly pathogenic avian influenza
17 October 2024
A new study published in Nature Communications has identified a new potential transmission route for H5 highly pathogenic avian influenza viruses (HPAI). Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
Liver fibrosis related to schistosomiasis is worsened by co-infection and other underlying liver diseases
15 October 2024
Researchers at Oxford Population Health and the Uganda Ministry of Health have presented new evidence assessing the effectiveness of the current indicators used by the World Health Organization (WHO) to identify likely cases or communities affected by periportal fibrosis (PPF) as a result of schistosomiasis. The study is published in The Lancet Microbe.
Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
14 October 2024
A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
Typhoid vaccine trial confirms sustained protection for older children
14 October 2024
A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.
New research network unites Oxford University’s global fight against antimicrobial resistance
8 October 2024
A new University-wide network on antimicrobial resistance aims to generate novel research and collaborations to tackle one of the most urgent global health threats.
Blog: End of life care in Vietnam
8 October 2024
Luu Phuoc An, a PhD student at NDM’s Oxford University Clinical Research Unit (OUCRU), is dedicated to improving end of life care in Vietnam. Her research explores the complex cultural, emotional, and medical aspects of death and dying in hospital settings.
MODRA Workshop Empowers Early-Career Scientists to Secure Competitive Research Grants
6 October 2024
The MORU-OUCRU Discovery Research Academy (MODRA) recently concluded its inaugural workshop in Bangkok. This intensive five-day programme equipped 15 promising postdoctoral researchers with the skills required to complete a high-quality seed proposal.
US adults in worse health than British counterparts at midlife
2 October 2024
US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford’s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.
New study to support WHO guideline changes
2 October 2024
A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.
New multidisciplinary programme to develop digital pandemic tools
27 September 2024
The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.
Expert Comment: Three key pillars to tackle antimicrobial resistance effectively
25 September 2024
Timothy Walsh, Director of Biology at the Ineos Oxford Institute for antimicrobial research outlines three priorities that global leaders must consider at the UN High-Level Meeting on AMR held today.
PSI seminar series launches with talk on pandemic control measures
25 September 2024
Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.
New point-of-care testing to improve antibiotic use in Vietnam
24 September 2024
High levels of acceptability for a point-of-care testing service to improve antibiotic distribution for in Vietnamese pharmacies have been discovered by the Oxford University Clinical Research Unit (OUCRU), part of the Nuffield Department of Medicine.
Oxford Martin School citizen science project helps improve detection of antibiotic resistance
19 September 2024
Antibiotic resistance poses one of the most urgent challenges to public health worldwide. During this process, bacteria acquire genetic mutations that help them to become resistant to antibiotics.
Urgent action needed to understand links between air pollution and mental health
19 September 2024
Leading scientists are calling for urgent global action to better understand the links between air pollution and mental health.